A broader question might be to what extent are companies being forced by the unreasonable demands of this 'clunky' system to make this kind of proposal. Isn't the proposal a response to something? MSAC would be wise to consider what that something is rather than issue statements shifting blame and insulting healthcare companies.
Where does the system end if statements like this become a feature of our decision-making?
July 8, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Surely this therapy is an example of our system at its absolute worst?
June 28, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 26 June
June 26, 2026 - - Podcast -
Guild says pharmacy a solution as AMA flags ambulance ramping crisis
June 26, 2026 - - Latest News -
Australia's next industry agreements might put more biologics squarely in the frame
June 26, 2026 - - Latest News -
Arrotex and CStone partner to bring new anti PD-L1 therapy to Australia and New Zealand
June 26, 2026 - - Latest News -
LENZ and Arrotex partner to bring once daily presbyopia treatment to Australia and New Zealand
June 25, 2026 - - Latest News -
New report highlights the risk of inaction on diabetes technology
June 25, 2026 - - Latest News


